Correlation Between Medipharm Labs and Delivra Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medipharm Labs and Delivra Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medipharm Labs and Delivra Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medipharm Labs Corp and Delivra Health Brands, you can compare the effects of market volatilities on Medipharm Labs and Delivra Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medipharm Labs with a short position of Delivra Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medipharm Labs and Delivra Health.

Diversification Opportunities for Medipharm Labs and Delivra Health

0.4
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Medipharm and Delivra is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Medipharm Labs Corp and Delivra Health Brands in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Delivra Health Brands and Medipharm Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medipharm Labs Corp are associated (or correlated) with Delivra Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Delivra Health Brands has no effect on the direction of Medipharm Labs i.e., Medipharm Labs and Delivra Health go up and down completely randomly.

Pair Corralation between Medipharm Labs and Delivra Health

Assuming the 90 days horizon Medipharm Labs Corp is expected to generate 0.38 times more return on investment than Delivra Health. However, Medipharm Labs Corp is 2.6 times less risky than Delivra Health. It trades about -0.02 of its potential returns per unit of risk. Delivra Health Brands is currently generating about -0.03 per unit of risk. If you would invest  5.00  in Medipharm Labs Corp on September 20, 2024 and sell it today you would lose (0.40) from holding Medipharm Labs Corp or give up 8.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Medipharm Labs Corp  vs.  Delivra Health Brands

 Performance 
       Timeline  
Medipharm Labs Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medipharm Labs Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward indicators, Medipharm Labs is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Delivra Health Brands 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Delivra Health Brands has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Medipharm Labs and Delivra Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medipharm Labs and Delivra Health

The main advantage of trading using opposite Medipharm Labs and Delivra Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medipharm Labs position performs unexpectedly, Delivra Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Delivra Health will offset losses from the drop in Delivra Health's long position.
The idea behind Medipharm Labs Corp and Delivra Health Brands pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.